According to Haizheng Pharmaceutical, recently, Haizheng Pharmaceutical and Chengdu Interstellar Space Exploration Technology Co., Ltd. held a strategic cooperation signing ceremony. This cross-border strategic cooperation marks Haizheng Pharmaceutical's official entry into the new space biopharmaceutical circuit. Fu Shiming, chairman of Interstellar Development, said that Interstellar Development will rely on the “Xingshi” in-orbit tests and sample return capabilities to provide Haizheng Pharmaceutical with a low-cost and repeatable space research portal.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.